We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
4 Reasons to Add Welltower Stock to Your Portfolio Right Now
Read MoreHide Full Article
Key Takeaways
{\"0\":\"Welltower has gained 9.8% in three months, outpacing the industry\'s 1% growth.\",\"1\":\"SHO portfolio shows 11 straight quarters of 20% SSNOI year-over-year growth.\",\"2\":\"The REIT ended Q2 2025 with $9.5B liquidity and stable credit ratings.\"}
Welltower Inc. (WELL - Free Report) boasts a diversified portfolio of healthcare real estate assets in the key markets of the United States, Canada and the U.K. The favorable senior housing industry, restructuring efforts, and a healthy balance sheet are likely to continue aiding this Toledo, OH-based healthcare real estate investment trust (REIT) in riding the growth curve.
Analysts seem bullish on this Zacks Rank #2 (Buy) company. The Zacks Consensus Estimate for WELL’s 2025 FFO per share has moved a cent northward over the past week to $5.07, with an expected rise of 17.4% from last year.
Shares of this company have gained 9.8% in the past three months compared with the industry’s 1% growth.
Image Source: Zacks Investment Research
Factors That Make Welltower a Solid Pick
Favorable SHO Portfolio Dynamics: Given an aging population and an expected rise in senior citizens’ healthcare expenditure, Welltower’s seniors’ housing operating (SHO) portfolio is well-poised to experience solid demand.
With a supply-demand imbalance, the portfolio is expected to experience sustained occupancy growth in 2025 and the coming years. Capitalizing on these positive aspects, Welltower’s SHO portfolio is well-prepared for compelling multiyear revenue growth.
The second quarter of 2025 marked the 11th consecutive quarter in which SHO’s same-store net operating income (SSNOI) year-over-year growth exceeded 20%. In 2025, management anticipated the SHO SSNOI to grow within 18.5-21.5%, driven by same-store revenue growth of 9.2%, occupancy rise of 360 basis points and expense increase of 5.25%.
Favorable OM Visit Trend: There has been a favorable outpatient visit trend compared with inpatient admissions. Banking on this, the company is optimizing its outpatient medical (OM) portfolio, growing relationships with health system partners, and deploying capital in strategic acquisitions.
Given the favorable secular trends and growing need for value-based care, the company’s efforts to strengthen its OM footprint will boost long-term growth.
Restructuring Efforts: Restructuring initiatives have enabled the company to attract top-class operators, facilitating the company to improve the quality of its cash flows.
From the beginning of the year through July 28, 2025, Welltower completed $3.96 billion of pro-rata gross investments, including $3.7 billion in acquisitions and loan funding, and $254.9 million in development funding.
Balance Sheet Strength: Welltower maintains a healthy balance sheet position. As of June 30, 2025, it had $9.5 billion of available liquidity. The net debt to adjusted EBITDA was 2.93X, improving from 3.68X year over year, as of June 30, 2025. Moreover, Welltower’s debt maturities are well-laddered, with a weighted average maturity of 5.8 years, thereby enhancing its financial flexibility.
In the first quarter of 2025, S&P Global Ratings and Moody's Investor Service raised their credit ratings related to the company to "A-" with a stable outlook and to "A3" with a stable outlook, respectively.
The Zacks Consensus Estimate for PLYM’s 2025 FFO per share has moved 2 cents northward to $1.88 over the past two months.
The Zacks Consensus Estimate for CCI’s 2025 FFO per share has moved 3 cents upward to $4.21 over the past two months.
Note: Anything related to earnings presented in this write-up represents funds from operations (FFO), a widely used metric to gauge the performance of REITs.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
4 Reasons to Add Welltower Stock to Your Portfolio Right Now
Key Takeaways
Welltower Inc. (WELL - Free Report) boasts a diversified portfolio of healthcare real estate assets in the key markets of the United States, Canada and the U.K. The favorable senior housing industry, restructuring efforts, and a healthy balance sheet are likely to continue aiding this Toledo, OH-based healthcare real estate investment trust (REIT) in riding the growth curve.
Analysts seem bullish on this Zacks Rank #2 (Buy) company. The Zacks Consensus Estimate for WELL’s 2025 FFO per share has moved a cent northward over the past week to $5.07, with an expected rise of 17.4% from last year.
Shares of this company have gained 9.8% in the past three months compared with the industry’s 1% growth.
Image Source: Zacks Investment Research
Factors That Make Welltower a Solid Pick
Favorable SHO Portfolio Dynamics: Given an aging population and an expected rise in senior citizens’ healthcare expenditure, Welltower’s seniors’ housing operating (SHO) portfolio is well-poised to experience solid demand.
With a supply-demand imbalance, the portfolio is expected to experience sustained occupancy growth in 2025 and the coming years. Capitalizing on these positive aspects, Welltower’s SHO portfolio is well-prepared for compelling multiyear revenue growth.
The second quarter of 2025 marked the 11th consecutive quarter in which SHO’s same-store net operating income (SSNOI) year-over-year growth exceeded 20%. In 2025, management anticipated the SHO SSNOI to grow within 18.5-21.5%, driven by same-store revenue growth of 9.2%, occupancy rise of 360 basis points and expense increase of 5.25%.
Favorable OM Visit Trend: There has been a favorable outpatient visit trend compared with inpatient admissions. Banking on this, the company is optimizing its outpatient medical (OM) portfolio, growing relationships with health system partners, and deploying capital in strategic acquisitions.
Given the favorable secular trends and growing need for value-based care, the company’s efforts to strengthen its OM footprint will boost long-term growth.
Restructuring Efforts: Restructuring initiatives have enabled the company to attract top-class operators, facilitating the company to improve the quality of its cash flows.
From the beginning of the year through July 28, 2025, Welltower completed $3.96 billion of pro-rata gross investments, including $3.7 billion in acquisitions and loan funding, and $254.9 million in development funding.
Balance Sheet Strength: Welltower maintains a healthy balance sheet position. As of June 30, 2025, it had $9.5 billion of available liquidity. The net debt to adjusted EBITDA was 2.93X, improving from 3.68X year over year, as of June 30, 2025. Moreover, Welltower’s debt maturities are well-laddered, with a weighted average maturity of 5.8 years, thereby enhancing its financial flexibility.
In the first quarter of 2025, S&P Global Ratings and Moody's Investor Service raised their credit ratings related to the company to "A-" with a stable outlook and to "A3" with a stable outlook, respectively.
Other Stocks to Consider
Some other top-ranked stocks from the broader REIT sector are Plymouth Industrial REIT (PLYM - Free Report) and Crown Castle (CCI - Free Report) , each carrying a Zacks Rank #2 at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for PLYM’s 2025 FFO per share has moved 2 cents northward to $1.88 over the past two months.
The Zacks Consensus Estimate for CCI’s 2025 FFO per share has moved 3 cents upward to $4.21 over the past two months.
Note: Anything related to earnings presented in this write-up represents funds from operations (FFO), a widely used metric to gauge the performance of REITs.